Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Salim I. Khakoo,1*
Chloe L. Thio,2
Maureen P. Martin,3
Collin R. Brooks,1
Xiaojiang Gao,3
Jacquie Astemborski,2
Jie Cheng,3
James J. Goedert,4
David Vlahov,5
Margaret Hilgartner,6
Steven Cox,7
Ann-Margeret Little,7
Graeme J. Alexander,8
Matthew E. Cramp,9
Stephen J. O'Brien,10
William M. C. Rosenberg,1
David L. Thomas,2
Mary Carrington3*
Abstract:
Natural killer (NK) cells provide a central defense againstviral infection by using inhibitory and activation receptorsfor major histocompatibility complex class I molecules as ameans of controlling their activity. We show that genes encodingthe inhibitory NK cell receptor KIR2DL3 and its human leukocyteantigen C group1 (HLA-C1) ligand directly influence resolutionof hepatitis C virus (HCV) infection. This effect was observedin Caucasians and African Americans with expected low infectiousdoses of HCV but not in those with high-dose exposure, in whomthe innate immune response is likely overwhelmed. The data stronglysuggest that inhibitory NK cell interactions are important indetermining antiviral immunity and that diminished inhibitoryresponses confer protection against HCV.
1 Liver Group, Division of Infection, Inflammation, and Repair, Southampton University, Southampton 5016 6YD, UK. 2 Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21231, USA. 3 Basic Research Program, Scientific Applications International Corporation Frederick, Inc., Laboratory of Genomic Diversity, NCI Frederick, Frederick, MD 21702, USA. 4 Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA. 5 New York Academy of Medicine, New York, NY 10029, USA. 6 Department of Pediatrics, New York Presbyterian HospitalCornell Medical Center, New York, NY 10021, USA. 7 Anthony Nolan Research Institute, The Royal Free Hospital, London NW3 2PF, UK. 8 Department of Medicine, University of Cambridge, Cambridge CD2 2QQ, UK. 9 Department of Gastroenterology, Derriford Hospital, Plymouth PL6 8DH, UK. 10 Laboratory of Genomic Diversity, National Cancer Institute, Frederick, MD 21702, USA.
* To whom correspondence should be addressed: E-mail: carringt{at}ncifcrf.gov (M.C.); sik{at}soton.ac.uk (S.I.K.)
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Peter Parham (6 August 2004) Science305 (5685), 786.
[DOI: 10.1126/science.1102025] |Summary »|Full Text »|PDF »
Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion.
D. Peppa, U. S. Gill, G. Reynolds, N. J. W. Easom, L. J. Pallett, A. Schurich, L. Micco, G. Nebbia, H. D. Singh, D. H. Adams, et al. (2013)
J. Exp. Med.
210, 99-114
|Abstract »|Full Text »|PDF »
Degenerate Recognition of MHC Class I Molecules with Bw4 and Bw6 Motifs by a Killer Cell Ig-like Receptor 3DL Expressed by Macaque NK Cells.
S. M. Maloveste, D. Chen, E. Gostick, J. P. Vivian, R. J. Plishka, R. Iyengar, R. L. Kruthers, A. Buckler-White, A. G. Brooks, J. Rossjohn, et al. (2012)
J. Immunol.
189, 4338-4348
|Abstract »|Full Text »|PDF »
CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.
N. K. Bjorkstrom, V. Beziat, F. Cichocki, L. L. Liu, J. Levine, S. Larsson, R. A. Koup, S. K. Anderson, H.-G. Ljunggren, and K.-J. Malmberg (2012)
Blood
120, 3455-3465
|Abstract »|Full Text »|PDF »
Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors.
W. Jiang, C. Johnson, J. Jayaraman, N. Simecek, J. Noble, M. F. Moffatt, W. O. Cookson, J. Trowsdale, and J. A. Traherne (2012)
Genome Res.
22, 1845-1854
|Abstract »|Full Text »|PDF »
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.
I. Jelcic, K. C. Hsu, K. Kakalacheva, P. Breiden, B. Dupont, M. Uhrberg, R. Martin, C. Munz, and J. D. Lunemann (2012)
Multiple Sclerosis Journal
18, 951-958
|Abstract »|Full Text »|PDF »
Frequent and Strong Antibody-Mediated Natural Killer Cell Activation in Response to HIV-1 Env in Individuals with Chronic HIV-1 Infection.
C. F. Thobakgale, L. Fadda, K. Lane, I. Toth, F. Pereyra, S. Bazner, T. Ndung'u, B. D. Walker, E. S. Rosenberg, G. Alter, et al. (2012)
J. Virol.
86, 6986-6993
|Abstract »|Full Text »|PDF »
Interferon {alpha}-Stimulated Natural Killer Cells From Patients With Acute Hepatitis C Virus (HCV) Infection Recognize HCV-Infected and Uninfected Hepatoma Cells via DNAX accessory molecule-1.
K. A. Stegmann, N. K. Bjorkstrom, S. Ciesek, S. Lunemann, J. Jaroszewicz, J. Wiegand, P. Malinski, L. B. Dustin, C. M. Rice, M. P. Manns, et al. (2012)
The Journal of Infectious Disease
205, 1351-1362
|Abstract »|Full Text »|PDF »
Genetically Associated CD16+56- Natural Killer Cell Interferon (IFN)-{alpha}R Expression Regulates Signaling and Is Implicated in IFN-{alpha}-Induced Hepatitis C Virus Decline.
S. J. Conry, Q. Meng, G. Hardy, N. L. Yonkers, J. M. Sugalski, A. Hirsch, P. Davitkov, A. Compan, Y. Falck-Ytter, R. E. Blanton, et al. (2012)
The Journal of Infectious Disease
205, 1131-1141
|Abstract »|Full Text »|PDF »
Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules.
P. Parham, P. J. Norman, L. Abi-Rached, and L. A. Guethlein (2012)
Phil Trans R Soc B
367, 800-811
|Abstract »|Full Text »|PDF »
Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.
P. A. Lang, K. S. Lang, H. C. Xu, M. Grusdat, I. A. Parish, M. Recher, A. R. Elford, S. Dhanji, N. Shaabani, C. W. Tran, et al. (2012)
PNAS
109, 1210-1215
|Abstract »|Full Text »|PDF »
Genetic Polymorphism in IL28B Is Associated With Spontaneous Clearance of Hepatitis C Virus Genotype 4 Infection in an Egyptian Cohort.
F. Kurbanov, M. Abdel-Hamid, R. Latanich, J. Astemborski, M. Mohamed, N. M. Mikhail, M. El-Daly, S. El-Kafrawy, D. L. Thomas, and C. L. Thio (2011)
The Journal of Infectious Disease
204, 1391-1394
|Abstract »|Full Text »|PDF »
Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral Therapy.
M. H. Kuniholm, X. Gao, X. Xue, A. Kovacs, K. Anastos, D. Marti, R. M. Greenblatt, M. H. Cohen, H. Minkoff, S. J. Gange, et al. (2011)
J. Virol.
85, 10826-10833
|Abstract »|Full Text »|PDF »
Do {lambda}-IFNs IL28A and IL28B act on human natural killer cells?.
B. Kramer, M. Eisenhardt, A. Glassner, C. Korner, T. Sauerbruch, U. Spengler, and J. Nattermann (2011)
PNAS
108, E519-E520
|Full Text »|PDF »
The Relation of HLA Genotype to Hepatitis C Viral Load and Markers of Liver Fibrosis in HIV-Infected and HIV-Uninfected Women.
M. H. Kuniholm, X. Gao, X. Xue, A. Kovacs, D. Marti, C. L. Thio, M. G. Peters, R. M. Greenblatt, J. J. Goedert, M. H. Cohen, et al. (2011)
The Journal of Infectious Disease
203, 1807-1814
|Abstract »|Full Text »|PDF »
Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection.
M. M. Dring, M. H. Morrison, B. P. McSharry, K. J. Guinan, R. Hagan, Irish HCV Research Consortium, C. O'Farrelly, and C. M. Gardiner (2011)
PNAS
108, 5736-5741
|Abstract »|Full Text »|PDF »
Innate immunity in alcoholic liver disease.
B. Gao, E. Seki, D. A. Brenner, S. Friedman, J. I. Cohen, L. Nagy, G. Szabo, and S. Zakhari (2011)
Am J Physiol Gastrointest Liver Physiol
300, G516-G525
|Abstract »|Full Text »|PDF »
Rhesus Macaque Inhibitory and Activating KIR3D Interact with Mamu-A-Encoded Ligands.
C. Rosner, P. H. Kruse, M. Hermes, N. Otto, and L. Walter (2011)
J. Immunol.
186, 2156-2163
|Abstract »|Full Text »|PDF »
NK Cells, Innate Immunity and Hepatitis C Infection after Liver Transplantation.
A. Nellore and J. A. Fishman (2011)
Clinical Infectious Diseases
52, 369-377
|Abstract »|Full Text »|PDF »
Natural killer cells and hepatitis C: action and reaction.
Analyses of HLA-C-specific KIR repertoires in donors with group A and B haplotypes suggest a ligand-instructed model of NK cell receptor acquisition.
K. Schonberg, M. Sribar, J. Enczmann, J. C. Fischer, and M. Uhrberg (2011)
Blood
117, 98-107
|Abstract »|Full Text »|PDF »
Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia.
S. Cooley, D. J. Weisdorf, L. A. Guethlein, J. P. Klein, T. Wang, C. T. Le, S. G. E. Marsh, D. Geraghty, S. Spellman, M. D. Haagenson, et al. (2010)
Blood
116, 2411-2419
|Abstract »|Full Text »|PDF »
Induction and Evasion of Innate Antiviral Responses by Hepatitis C Virus.
Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.
Y. Kimoto, T. Horiuchi, H. Tsukamoto, C. Kiyohara, H. Mitoma, A. Uchino, I. Furugo, S. Yoshizawa, A. Ueda, S. Harashima, et al. (2010)
Rheumatology
49, 1346-1353
|Abstract »|Full Text »|PDF »
Peptide antagonism as a mechanism for NK cell activation.
L. Fadda, G. Borhis, P. Ahmed, K. Cheent, S. V. Pageon, A. Cazaly, S. Stathopoulos, D. Middleton, A. Mulder, F. H. J. Claas, et al. (2010)
PNAS
107, 10160-10165
|Abstract »|Full Text »|PDF »
Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.
MHC class I Dk expression in hematopoietic and nonhematopoietic cells confers natural killer cell resistance to murine cytomegalovirus.
X. Xie, M. D. Stadnisky, E. R. Coats, M. M. Ahmed Rahim, A. Lundgren, W. Xu, A. P. Makrigiannis, and M. G. Brown (2010)
PNAS
107, 8754-8759
|Abstract »|Full Text »|PDF »
Large-Scale Candidate Gene Analysis of Spontaneous Clearance of Hepatitis C Virus.
T. L. Mosbruger, P. Duggal, J. J. Goedert, G. D. Kirk, W. K. Hoots, L. H. Tobler, M. Busch, M. G. Peters, H. R. Rosen, D. L. Thomas, et al. (2010)
The Journal of Infectious Disease
201, 1371-1380
|Abstract »|Full Text »|PDF »
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.
J. M. Venstrom, T. A. Gooley, S. Spellman, J. Pring, M. Malkki, B. Dupont, E. Petersdorf, and K. C. Hsu (2010)
Blood
115, 3162-3165
|Abstract »|Full Text »|PDF »
Effects of MHC Class I Alleles on Licensing of Ly49A+ NK Cells.
A. H. Jonsson, L. Yang, S. Kim, S. M. Taffner, and W. M. Yokoyama (2010)
J. Immunol.
184, 3424-3432
|Abstract »|Full Text »|PDF »
Intrahepatic IL-10 Maintains NKG2A+Ly49- Liver NK Cells in a Functionally Hyporesponsive State.
M. G. Lassen, J. R. Lukens, J. S. Dolina, M. G. Brown, and Y. S. Hahn (2010)
J. Immunol.
184, 2693-2701
|Abstract »|Full Text »|PDF »
HIV Protective KIR3DL1 and HLA-B Genotypes Influence NK Cell Function Following Stimulation with HLA-Devoid Cells.
S. Boulet, R. Song, P. Kamya, J. Bruneau, N. H. Shoukry, C. M. Tsoukas, and N. F. Bernard (2010)
J. Immunol.
184, 2057-2064
|Abstract »|Full Text »|PDF »
A Small, Variable, and Irregular Killer Cell Ig-Like Receptor Locus Accompanies the Absence of MHC-C and MHC-G in Gibbons.
L. Abi-Rached, H. Kuhl, C. Roos, B. ten Hallers, B. Zhu, L. Carbone, P. J. de Jong, A. R. Mootnick, F. Knaust, R. Reinhardt, et al. (2010)
J. Immunol.
184, 1379-1391
|Abstract »|Full Text »|PDF »
Effect of Killer Immunoglobulin-Like Receptors in the Response to Combined Treatment in Patients with Chronic Hepatitis C Virus Infection.
J. R. Vidal-Castineira, A. Lopez-Vazquez, R. Diaz-Pena, R. Alonso-Arias, J. Martinez-Borra, R. Perez, J. Fernandez-Suarez, S. Melon, J. Prieto, L. Rodrigo, et al. (2010)
J. Virol.
84, 475-481
|Abstract »|Full Text »|PDF »
IPD--the Immuno Polymorphism Database.
J. Robinson, K. Mistry, H. McWilliam, R. Lopez, and S. G. E. Marsh (2010)
Nucleic Acids Res.
38, D863-D869
|Abstract »|Full Text »|PDF »
KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma.
J. M. Venstrom, J. Zheng, N. Noor, K. E. Danis, A. W. Yeh, I. Y. Cheung, B. Dupont, R. J. O'Reilly, N.-K. V. Cheung, and K. C. Hsu (2009)
Clin. Cancer Res.
15, 7330-7334
|Abstract »|Full Text »|PDF »
Expansion of Functionally Skewed CD56-Negative NK Cells in Chronic Hepatitis C Virus Infection: Correlation with Outcome of Pegylated IFN-{alpha} and Ribavirin Treatment.
V. D. Gonzalez, K. Falconer, N. K. Bjorkstrom, K. G. Blom, O. Weiland, H.-G. Ljunggren, A. Alaeus, and J. K. Sandberg (2009)
J. Immunol.
183, 6612-6618
|Abstract »|Full Text »|PDF »
Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands.
K. Gendzekhadze, P. J. Norman, L. Abi-Rached, T. Graef, A. K. Moesta, Z. Layrisse, and P. Parham (2009)
PNAS
106, 18692-18697
|Abstract »|Full Text »|PDF »
Impaired Plasmacytoid Dendritic Cell (PDC)-NK Cell Activity in Viremic Human Immunodeficiency Virus Infection Attributable to Impairments in both PDC and NK Cell Function.
S. J. Conry, K. A. Milkovich, N. L. Yonkers, B. Rodriguez, H. B. Bernstein, R. Asaad, F. P. Heinzel, M. Tary-Lehmann, M. M. Lederman, and D. D. Anthony (2009)
J. Virol.
83, 11175-11187
|Abstract »|Full Text »|PDF »
Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection.
K. Page, J. A. Hahn, J. Evans, S. Shiboski, P. Lum, E. Delwart, L. Tobler, W. Andrews, L. Avanesyan, S. Cooper, et al. (2009)
The Journal of Infectious Disease
200, 1216-1226
|Abstract »|Full Text »|PDF »
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases.
HLA Class I Subtype-Dependent Expansion of KIR3DS1+ and KIR3DL1+ NK Cells during Acute Human Immunodeficiency Virus Type 1 Infection.
G. Alter, S. Rihn, K. Walter, A. Nolting, M. Martin, E. S. Rosenberg, J. S. Miller, M. Carrington, and M. Altfeld (2009)
J. Virol.
83, 6798-6805
|Abstract »|Full Text »|PDF »
Phenotypic and Functional Analyses of KIR3DL1+ and KIR3DS1+ NK Cell Subsets Demonstrate Differential Regulation by Bw4 Molecules and Induced KIR3DS1 Expression on Stimulated NK Cells.
M. Morvan, C. Willem, K. Gagne, N. Kerdudou, G. David, V. Sebille, G. Follea, J.-D. Bignon, and C. Retiere (2009)
J. Immunol.
182, 6727-6735
|Abstract »|Full Text »|PDF »
The transcription factor c-Myc enhances KIR gene transcription through direct binding to an upstream distal promoter element.
F. Cichocki, R. J. Hanson, T. Lenvik, M. Pitt, V. McCullar, H. Li, S. K. Anderson, and J. S. Miller (2009)
Blood
113, 3245-3253
|Abstract »|Full Text »|PDF »
Macrophages in Hepatitis B and Hepatitis C Virus Infections.
Evolution and Survival of Marine Carnivores Did Not Require a Diversity of Killer Cell Ig-Like Receptors or Ly49 NK Cell Receptors.
J. A. Hammond, L. A. Guethlein, L. Abi-Rached, A. K. Moesta, and P. Parham (2009)
J. Immunol.
182, 3618-3627
|Abstract »|Full Text »|PDF »
The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells.
P. Brodin, T. Lakshmikanth, S. Johansson, K. Karre, and P. Hoglund (2009)
Blood
113, 2434-2441
|Abstract »|Full Text »|PDF »
Nucleophosmin Is Cleaved and Inactivated by the Cytotoxic Granule Protease Granzyme M during Natural Killer Cell-mediated Killing.
S. P. Cullen, I. S. Afonina, R. Donadini, A. U. Luthi, J. P. Medema, P. I. Bird, and S. J. Martin (2009)
J. Biol. Chem.
284, 5137-5147
|Abstract »|Full Text »|PDF »
Complete Characterization of Killer Ig-Like Receptor (KIR) Haplotypes in Mauritian Cynomolgus Macaques: Novel Insights into Nonhuman Primate KIR Gene Content and Organization.
B. N. Bimber, A. J. Moreland, R. W. Wiseman, A. L. Hughes, and D. H. O'Connor (2008)
J. Immunol.
181, 6301-6308
|Abstract »|Full Text »|PDF »
Regulatory Polymorphisms in the Interleukin-18 Promoter Are Associated with Hepatitis C Virus Clearance.
P. An, C. L. Thio, G. D. Kirk, S. Donfield, J. J. Goedert, and C. A. Winkler (2008)
The Journal of Infectious Disease
198, 1159-1165
|Abstract »|Full Text »|PDF »
Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure.
L Golden-Mason, L Madrigal-Estebas, E McGrath, M J Conroy, E J Ryan, J E Hegarty, C O'Farrelly, and D G Doherty (2008)
Gut
57, 1121-1128
|Abstract »|Full Text »|PDF »
Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
A. Iannello, O. Debbeche, S. Samarani, and A. Ahmad (2008)
J. Leukoc. Biol.
84, 1-26
|Abstract »|Full Text »|PDF »
Killer Ig-Like Receptor Expression in Uterine NK Cells Is Biased toward Recognition of HLA-C and Alters with Gestational Age.
A. M. Sharkey, L. Gardner, S. Hiby, L. Farrell, R. Apps, L. Masters, J. Goodridge, L. Lathbury, C. A. Stewart, S. Verma, et al. (2008)
J. Immunol.
181, 39-46
|Abstract »|Full Text »|PDF »
Synergistic Polymorphism at Two Positions Distal to the Ligand-Binding Site Makes KIR2DL2 a Stronger Receptor for HLA-C Than KIR2DL3.
A. K. Moesta, P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham (2008)
J. Immunol.
180, 3969-3979
|Abstract »|Full Text »|PDF »
HLA alleles determine differences in human natural killer cell responsiveness and potency.
S. Kim, J. B. Sunwoo, L. Yang, T. Choi, Y.-J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al. (2008)
PNAS
105, 3053-3058
|Abstract »|Full Text »|PDF »
Testing Strategy To Identify Cases of Acute Hepatitis C Virus (HCV) Infection and To Project HCV Incidence Rates.
K. Page-Shafer, B. L. Pappalardo, L. H. Tobler, B. H. Phelps, B. R. Edlin, A. R. Moss, T. L. Wright, D. J. Wright, T. R. O'Brien, S. Caglioti, et al. (2008)
J. Clin. Microbiol.
46, 499-506
|Abstract »|Full Text »|PDF »
Differential natural killer cell mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes.
G. Alter, M. P. Martin, N. Teigen, W. H. Carr, T. J. Suscovich, A. Schneidewind, H. Streeck, M. Waring, A. Meier, C. Brander, et al. (2007)
J. Exp. Med.
204, 3027-3036
|Abstract »|Full Text »|PDF »
Intrahepatic Lymphocyte Expression of Dipeptidyl Peptidase I-Processed Granzyme B and Perforin Induces Hepatocyte Expression of Serine Proteinase Inhibitor 6 (Serpinb9/SPI-6).
H. W. Stout-Delgado, Y. Getachew, B. C. Miller, and D. L. Thiele (2007)
J. Immunol.
179, 6561-6567
|Abstract »|Full Text »|PDF »
Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 Infection.
V. Pascal, E. Yamada, M. P. Martin, G. Alter, M. Altfeld, J. A. Metcalf, M. W. Baseler, J. W. Adelsberger, M. Carrington, S. K. Anderson, et al. (2007)
J. Immunol.
179, 1625-1633
|Abstract »|Full Text »|PDF »
KIR2DS1-Positive NK Cells Mediate Alloresponse against the C2 HLA-KIR Ligand Group In Vitro.
J. H. Chewning, C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont (2007)
J. Immunol.
179, 854-868
|Abstract »|Full Text »|PDF »
Protection from Lethal Infection by Adoptive Transfer of CD8 T Cells Genetically Engineered to Express Virus-Specific Innate Immune Receptor.
K. Iizuka, C. Nakajima, Y.-M. Iizuka, M. Takase, T. Kato, S. Noda, K. Tanaka, and O. Kanagawa (2007)
J. Immunol.
179, 1122-1128
|Abstract »|Full Text »|PDF »
Evolution of Killer Cell Ig-Like Receptor (KIR) Genes: Definition of an Orangutan KIR Haplotype Reveals Expansion of Lineage III KIR Associated with the Emergence of MHC-C.
L. A. Guethlein, A. M. Older Aguilar, L. Abi-Rached, and P. Parham (2007)
J. Immunol.
179, 491-504
|Abstract »|Full Text »|PDF »
Genetic Susceptibility, HIV Infection, and the Kidney.
K. Kiryluk, J. Martino, and A. G. Gharavi (2007)
Clin. J. Am. Soc. Nephrol.
2, S25-S35
|Abstract »|Full Text »|PDF »
S. Ravet, D. Scott-Algara, E. Bonnet, H. K. Tran, T. Tran, N. Nguyen, L. X. Truong, I. Theodorou, F. Barre-Sinoussi, G. Pancino, et al. (2007)
Blood
109, 4296-4305
|Abstract »|Full Text »|PDF »
Differential NKp30 Inducibility in Chimpanzee NK Cells and Conserved NK Cell Phenotype and Function in Long-Term HIV-1-Infected Animals.
E. Rutjens, S. Mazza, R. Biassoni, G. Koopman, L. Radic, M. Fogli, P. Costa, M. C. Mingari, L. Moretta, J. Heeney, et al. (2007)
J. Immunol.
178, 1702-1712
|Abstract »|Full Text »|PDF »
Deficient Major Histocompatibility Complex-Linked Innate Murine Cytomegalovirus Immunity in MA/My.L-H2b Mice and Viral Downregulation of H-2k Class I Proteins.
X. Xie, A. Dighe, P. Clark, P. Sabastian, S. Buss, and M. G. Brown (2007)
J. Virol.
81, 229-236
|Abstract »|Full Text »|PDF »
Cutting Edge: Resistance to HIV-1 Infection among African Female Sex Workers Is Associated with Inhibitory KIR in the Absence of Their HLA Ligands.
W. Jennes, S. Verheyden, C. Demanet, C. A. Adje-Toure, B. Vuylsteke, J. N. Nkengasong, and L. Kestens (2006)
J. Immunol.
177, 6588-6592
|Abstract »|Full Text »|PDF »
A Single Polymorphism Disrupts the Killer Ig-Like Receptor 2DL2/2DL3 D1 Domain.
C. J. VandenBussche, S. Dakshanamurthy, P. E. Posch, and C. K. Hurley (2006)
J. Immunol.
177, 5347-5357
|Abstract »|Full Text »|PDF »
Gender Susceptibility to Chronic Hepatitis C Virus Infection Associated with Interleukin 10 Promoter Polymorphism.
N. Paladino, H. Fainboim, G. Theiler, T. Schroder, A. E. Munoz, A. C. Flores, O. Galdame, and L. Fainboim (2006)
J. Virol.
80, 9144-9150
|Abstract »|Full Text »|PDF »
CCR5 in T Cell-Mediated Liver Diseases: What's Going On?.
M. N. Ajuebor, J. A. Carey, and M. G. Swain (2006)
J. Immunol.
177, 2039-2045
|Abstract »|Full Text »|PDF »
Natural Killer Receptors on CD8 T Cells and Natural Killer Cells from Different HLA-C Phenotypes in Melanoma Patients..
J. A. Campillo, J. A. Martinez-Escribano, M. R. Moya-Quiles, L. A. Marin, M. Muro, N. Guerra, A. Parrado, M. Campos, J. F. Frias, A. Minguela, et al. (2006)
Clin. Cancer Res.
12, 4822-4831
|Abstract »|Full Text »|PDF »
Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
R Dawes, B Hennig, W Irving, S Petrova, S Boxall, V Ward, D Wallace, D C Macallan, M Thursz, A Hill, et al. (2006)
J. Med. Genet.
43, 678-684
|Abstract »|Full Text »|PDF »
Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.
J Nattermann, G Feldmann, G Ahlenstiel, B Langhans, T Sauerbruch, and U Spengler (2006)
Gut
55, 869-877
|Abstract »|Full Text »|PDF »
Association of Transforming Growth Factor-{beta}1 Functional Polymorphisms with Natural Clearance of Hepatitis C Virus.
T. Kimura, T. Saito, M. Yoshimura, S. Yixuan, M. Baba, G. Ji, M. Muramatsu, and S. Kawata (2006)
The Journal of Infectious Disease
193, 1371-1374
|Abstract »|Full Text »|PDF »
Cmv4, a New Locus Linked to the NK Cell Gene Complex, Controls Innate Resistance to Cytomegalovirus in Wild-Derived Mice.
S. G. Adam, A. Caraux, N. Fodil-Cornu, J. C. Loredo-Osti, S. Lesjean-Pottier, J. Jaubert, I. Bubic, S. Jonjic, J.-L. Guenet, S. M. Vidal, et al. (2006)
J. Immunol.
176, 5478-5485
|Abstract »|Full Text »|PDF »
Apolipoprotein {varepsilon}3 allele is associated with persistent hepatitis C virus infection.
D A Price, M F Bassendine, S M Norris, C Golding, G L Toms, M L Schmid, C M Morris, A D Burt, and P T Donaldson (2006)
Gut
55, 715-718
|Abstract »|Full Text »|PDF »
Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function.
M. Yawata, N. Yawata, M. Draghi, A.-M. Little, F. Partheniou, and P. Parham (2006)
J. Exp. Med.
203, 633-645
|Abstract »|Full Text »|PDF »
Genetic Polymorphism of Fc.
J. P. Pandey; and J. M. Woof (2006)
Science
311, 1376d-1377d
|Full Text »|PDF »
Epidemiological and Genetic Correlates of Severe Acute Respiratory Syndrome Coronavirus Infection in the Hospital with the Highest Nosocomial Infection Rate in Taiwan in 2003.
Y.-M. A. Chen, S.-Y. Liang, Y.-P. Shih, C.-Y. Chen, Y.-M. Lee, L. Chang, S.-Y. Jung, M.-S. Ho, K.-Y. Liang, H.-Y. Chen, et al. (2006)
J. Clin. Microbiol.
44, 359-365
|Abstract »|Full Text »|PDF »
Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation.
M. Cook, D. Briggs, C. Craddock, P. Mahendra, D. Milligan, C. Fegan, P. Darbyshire, S. Lawson, E. Boxall, and P. Moss (2006)
Blood
107, 1230-1232
|Abstract »|Full Text »|PDF »
The Inhibitory Receptor NKG2A Determines Lysis of Vaccinia Virus-Infected Autologous Targets by NK Cells.
C. R. Brooks, T. Elliott, P. Parham, and S. I. Khakoo (2006)
J. Immunol.
176, 1141-1147
|Abstract »|Full Text »|PDF »
Requisite H2k Role in NK Cell-Mediated Resistance in Acute Murine Cytomegalovirus-Infected MA/My Mice.
A. Dighe, M. Rodriguez, P. Sabastian, X. Xie, M. McVoy, and M. G. Brown (2005)
J. Immunol.
175, 6820-6828
|Abstract »|Full Text »|PDF »
Killer Cell Ig-Like Receptor-Dependent Signaling by Ig-Like Transcript 2 (ILT2/CD85j/LILRB1/LIR-1).
Shared Alterations in NK Cell Frequency, Phenotype, and Function in Chronic Human Immunodeficiency Virus and Hepatitis C Virus Infections.
U.-C. Meier, R. E. Owen, E. Taylor, A. Worth, N. Naoumov, C. Willberg, K. Tang, P. Newton, P. Pellegrino, I. Williams, et al. (2005)
J. Virol.
79, 12365-12374
|Abstract »|Full Text »|PDF »
Natural-killer cells and dendritic cells: "l'union fait la force".
T. Walzer, M. Dalod, S. H. Robbins, L. Zitvogel, and E. Vivier (2005)
Blood
106, 2252-2258
|Abstract »|Full Text »|PDF »
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.
C. A. Stewart, F. Laugier-Anfossi, F. Vely, X. Saulquin, J. Riedmuller, A. Tisserant, L. Gauthier, F. Romagne, G. Ferracci, F. A. Arosa, et al. (2005)
PNAS
102, 13224-13229
|Abstract »|Full Text »|PDF »
Multiple Cytokines Regulate the NK Gene Complex-Encoded Receptor Repertoire of Mature NK Cells and T Cells.
F. Gays, K. Martin, R. Kenefeck, J. G. Aust, and C. G. Brooks (2005)
J. Immunol.
175, 2938-2947
|Abstract »|Full Text »|PDF »
Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis.
K. Kuroki, N. Tsuchiya, M. Shiroishi, L. Rasubala, Y. Yamashita, K. Matsuta, T. Fukazawa, M. Kusaoi, Y. Murakami, M. Takiguchi, et al. (2005)
Hum. Mol. Genet.
14, 2469-2480
|Abstract »|Full Text »|PDF »
Protective Effect of the HLA-Bw4I80 Epitope and the Killer Cell Immunoglobulin-Like Receptor 3DS1 Gene against the Development of Hepatocellular Carcinoma in Patients with Hepatitis C Virus Infection.
A. Lopez-Vazquez, L. Rodrigo, J. Martinez-Borra, R. Perez, M. Rodriguez, J. L. Fdez-Morera, D. Fuentes, S. Rodriguez-Rodero, S. Gonzalez, and C. Lopez-Larrea (2005)
The Journal of Infectious Disease
192, 162-165
|Abstract »|Full Text »|PDF »